12 drug makers likely to file complaint against data fabrication

A total number of 12 local pharmaceutical firms are threatening to lodge their complaints against the cancellation of their generic products, following the recent announcement of the Korea Food and Drug Administration that a number of domestic bioresearch centers and pharmaceutical schools have been found to have fabricated test results of generic drugs.

Private experts these firms have been...